AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimith MF 3mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Johnlee Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Glimith MF 3mg/500mg Tablet SR

Diabexe Duo 3mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication manages type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, presenting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Uses of Glimith MF 3mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimith MF 3mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Glimith MF 3mg/500mg Extended-Release Tablets with a meal.

Common Side effects of Glimith MF 3mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimith MF 3mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimith MF 3mg/500mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with food.

How Glimith MF 3mg/500mg Tablet SR works:

Glimepiride/Metformin 3mg/500mg Extended-Release Tablets (Glimith MF) combine two distinct antidiabetic agents to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through a triple mechanism: decreasing hepatic glucose output, retarding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimith MF 3mg/500mg Tablet SR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimith MF 3mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glimith MF 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates a potential for infant harm due to the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimith MF 3mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimith MF 3mg/500mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver disease, initiate treatment with a reduced Glimith MF 3mg/500mg Tablet SR dosage; its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Glimith MF 3mg/500mg Tablet SR :

Should you forget a Glimith MF 3mg/500mg Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimith MF 3mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimith MF 3mg/500mg Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glimith MF 3mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimith MF 3mg/500mg Tablet SR and seek immediate medical attention.
Glimith MF 3mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 DM.
Glimith MF 3mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimith MF 3mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Glimith MF 3mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimith MF 3mg/500mg SR tablets with alcohol is unsafe. Alcohol can further reduce blood sugar, risking hypoglycemia, and increase the likelihood of lactic acidosis.
Glimith MF 3mg/500mg Tabl...
45
MRP 52
13% off